Current:Home > reviewsJudge issues interim stay of New York AG's $250M fraud suit against Trump: Sources -消息
Judge issues interim stay of New York AG's $250M fraud suit against Trump: Sources
View
Date:2025-04-18 05:49:25
A New York appellate judge on Thursday issued an interim stay of the state attorney general's $250 million civil fraud lawsuit against former President Donald Trump that is scheduled to go on trial Oct. 2, sources familiar with the matter tell ABC News.
The judge's order was issued during a previously unscheduled virtual hearing that was not open to the public.
The Appellate Division's First Department will now hear Trump's request to delay the trial.
MORE: New York AG seeks legal sanctions against Trump as part of $250M lawsuit
Responding to the ruling, Attorney General Letitia James said, "We are confident in our case and will be ready for trial."
Whether the trial starts as scheduled next month will depend on how quickly the panel hears the arguments and renders a decision.
Before trial can start, Trump's attorneys said that Judge Arthur Engoron is obliged to decide whether the attorney general's case -- which covers more than a decade of allegedly fraudulent business conduct -- should be narrowed. Trump's legal team has argued some of the real estate transactions are too old to be considered.
Trump's team is now taking the aggressive step of suing Engoron to force him to rule.
Engoron has said the trial would start on Oct. 2 "come hell or high water."
James last year brought the $250 million lawsuit against Trump, his children and his company that accuses them of "grossly" inflating the former president's net worth by billions of dollars and cheating lenders and others with false and misleading financial statements.
Trump has denied all wrongdoing.
veryGood! (13)
Related
- Former longtime South Carolina congressman John Spratt dies at 82
- Brittany Snow and Tyler Stanaland Finalize Divorce 9 Months After Breakup
- Parties at COP27 Add Loss and Damage to the Agenda, But Won’t Discuss Which Countries Are Responsible or Who Should Pay
- Why Beyoncé Just Canceled an Upcoming Stop on Her Renaissance Tour
- Pressure on a veteran and senator shows what’s next for those who oppose Trump
- You’ll Roar Over Katy Perry and Orlando Bloom’s PDA Moments at Wimbledon Match
- Daniel Radcliffe Shares Rare Insight Into His Magical New Chapter as a Dad
- With Build Back Better Stalled, Expanded Funding for a Civilian Climate Corps Hangs in the Balance
- Jamie Foxx gets stitches after a glass is thrown at him during dinner in Beverly Hills
- Republicans Eye the SEC’s Climate-Related Disclosure Regulations, Should They Take Control of Congress
Ranking
- Pregnant Kylie Kelce Shares Hilarious Question Her Daughter Asked Jason Kelce Amid Rising Fame
- Racing Driver Dilano van ’T Hoff’s Girlfriend Mourns His Death at Age 18
- A record number of Americans may fly this summer. Here's everything you need to know
- Every Hour, This Gas Storage Station Sends Half a Ton of Methane Into the Atmosphere
- Louvre will undergo expansion and restoration project, Macron says
- Target removes some Pride Month products after threats against employees
- How a cat rescue worker created an internet splash with a 'CatVana' adoption campaign
- Sarah Ferguson, Duchess of York, Shares Update After Undergoing Surgery for Breast Cancer
Recommendation
Cincinnati Bengals quarterback Joe Burrow owns a $3 million Batmobile Tumbler
If you haven't logged into your Google account in over 2 years, it will be deleted
Cardi B's Head-Turning Paris Fashion Week Looks Will Please You
Inside Clean Energy: As Efficiency Rises, Solar Power Needs Fewer Acres to Pack the Same Punch
Backstage at New York's Jingle Ball with Jimmy Fallon, 'Queer Eye' and Meghan Trainor
California Climate Measure Fails After ‘Green’ Governor Opposed It in a Campaign Supporters Called ‘Misleading’
Without Significant Greenhouse Gas Reductions, Countries in the Tropics and Subtropics Could Face ‘Extreme’ Heat Danger by 2100, a New Study Concludes
Families scramble to find growth hormone drug as shortage drags on